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ABSTRACT 
 
Holoprosencephaly (HPE) is the most common congenital cerebral malformation, 
characterized by impaired forebrain cleavage and midline facial anomalies. Heterozygous 
mutations in 14 genes have been associated with HPE, and are often inherited from an 
unaffected parent underlying complex genetic bases. It is now emerging that HPE may result 
from a combination of multiple genetic events, rather than from a single heterozygous 
mutation. To explore this hypothesis, we undertook whole exome sequencing (WES) and 
targeted high-throughput sequencing approaches to identify mutations in HPE subjects. We 
report here two HPE families in which two mutations are implicated in the disease. In the first 
family presenting two fetuses with alobar and semi-lobar HPE, we found mutations in two 
genes involved in HPE, SHH and DISP1, inherited respectively from the father and the 
mother. The second reported case is a family with a 9-year old girl presenting lobar HPE, 
harbouring two compound heterozygous mutations in DISP1. Together, these cases of digenic 
inheritance SHH/DISP1 and autosomal recessive HPE suggest that in some families, several 
genetic events are necessary to cause HPE. This study highlights the complexity of HPE 
inheritance and has to be taken into account by clinicians to improve HPE genetic counseling.  
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INTRODUCTION 
 
Holoprosencephaly (HPE) is the most frequent cerebral malformation, with an occurrence of 
approximately 1 in 250 embryos and 1.31 in 10,000 births (1). HPE is characterized by a 
failure to define the midline of the forebrain and midface, with different degrees of severity 
from a lobar brain to alobar forms associated with cyclopia. Mild manifestations or 
microforms include ocular hypotelorism, microcephaly and a single central maxillary incisor 
(2). The mode of inheritance of HPE has been extensively discussed in the literature, and 
several genetic models have been proposed: autosomal dominant transmission, autosomal 
recessive transmission or association of mutations in multiple genes (2-5). All these studies 
point out a strong genetic heterogeneity, with several causative genes identified (Table 1). It 
mostly implicates heterozygous mutations in SHH, ZIC2, SIX3 and TGIF1, which are 
considered as the four major genes involved in HPE. Heterozygous mutations in the minor 
genes GLI2, PTCH1, DISP1, FOXH1, NODAL, TDGF1, CDON, GAS1, DLL1 and FGF8 
have been identified with a lower frequency (2, 6, 7). Recently, two recessive inheritance 
cases of HPE have been described, implicating mutations in the gene STIL (Table 1) (8, 9). 
Importantly, these genes are all involved in signalling pathways implicated in brain 
development (4, 9-16) and alteration of SHH signalling appears to be the most common cause 
of HPE (17). 
 
Although the major genes have been formally involved, their penetrance is usually incomplete 
with an intra-familial phenotypic variability. Actually, mutations located in these genes are 
inherited from a parent, asymptomatic or displaying a microform of HPE, in 70% of the cases 
(2). For example, the same SHH mutation can be found in individuals harbouring either alobar 
HPE or minor forms (18). Consequently, the clinical variability could be due to abnormalities 
in other genes that have a function in the same or interacting signalling pathways (19, 20). 
 
This is strongly supported by the description of mouse models carrying mutations in two 
genes of the same or different signalling pathways. For example, whereas Gas1-/- mutant 
mice exhibit partial fusion of the medial nasal processes and Shh+/- mice appear normal, 
Gas1-/-;Shh+/- mice embryos display complete fusion of the medial nasal processes (21), 
reminiscent of a HPE phenotype. Such examples of animal models are numerous and all 
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support the hypothesis that HPE could be due to a cumulative partial inhibition of signalling 
pathways implicated in forebrain development (6, 22). 
 
However, there are only a few examples in the literature that suggest that HPE could be 
related to combined failures of several HPE genes in human (Table 2), including patients with 
co-occurring mutations or deletions in SHH/TGIF1 and SHH/ZIC2 (23). Nevertheless, 
sequencing of the four major genes (SHH, ZIC2, TGIF1, SIX3) in large HPE cohorts has not 
allowed to validate this hypothesis (2, 5, 14). Thus, the mode of inheritance of HPE is still 
unclear. 
 
Identifying more genes in families in which polygenic inheritance is suspected would be very 
beneficial to understand the pathogenic mechanism of this developmental disorder. This is 
now facilitated by the recent development of next generation sequencing technologies (20). In 
this study, we performed whole exome sequencing (WES) in a family where the father carries 
a mutation in SHH, transmitted to 3 fetuses with semi-lobar and alobar HPE. We 
hypothesized that the fetuses have all inherited a second mutation in another gene from the 
mother. This original strategy was powerful as it revealed a second mutation in DISP1 shared 
by the mother and the HPE fetuses. This family is the first one in which mutations in the two 
HPE-associated genes, SHH and DISP1, have been identified. Furthermore using a targeted 
NGS method, the involvement of DISP1 in HPE was reinforced by the observation of two 
DISP1 compound heterozygous mutations in another HPE family. These results support the 
complexity of HPE inheritance and raise important questions about how clinicians should 
consider the inheritance mode of HPE. 
 
MATERIALS AND METHODS 
 
Patients and samples 
Patients presenting midline abnormalities and suspicion of holoprosencephaly were referred 
from the Centre Hospitalier Universitaire of Rennes (France) and the Hôpital Cochin (Paris, 
France) through the network of reference centres for developmental anomalies and 
malformation syndromes (CLAD centres). Patients and parents blood and tissue samples were 
obtained from the processing of biological samples through the Centre de Ressources 
Biologiques (CRB) Santé of Rennes BB-0033-00056 (http://www.crbsante-rennes.com). The 
research protocol was conducted under French legal guidelines and fulfilled the requirements 
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of the local institutional ethics committee. The parents of the photographed patient assented to 
include photographs in a scientific publication. 
 
F1 family  
The mother II2 had three terminations of pregnancy with fetuses (III1, III2 and III3) 
harbouring semi-lobar or alobar HPE (Fig. 1a and Table 3a). The F1 family also includes two 
other healthy girls III4 and III5, being 12 and 11 years old respectively. The father II1, the 
grandfather I1 and the uncle II3 all present microcephaly. This latter had 4 children among 
which 3 (III6, III7 and III9) harbour microcephaly and minor facial midline malformations 
(hypotelorism). The father II1 also had two healthy siblings, II5 and II6 (Table 3a). DNA was 
available for all family members except II4. 
 
F2 family 
The F2 family includes three members, the two healthy parents I1 and I2 and their 9-year old 
girl II1 who displayed a lobar HPE (Fig. 2 and Table 3b). She has two healthy siblings but 
their DNA was not available. Pregnancy was normal. A wide cleft palate was observed at 
birth, which was surgically treated. II1 was then referred to genetic counselling at 5-and-half-
years old for psychomotor retardation (started walking at 21 months and had a language 
delay) and learning difficulties. On clinical examination, she weighed 16.5 kg (-1 standard 
deviation), was 109.5 cm tall, and had microcephaly (-2SD). She presented facial dysmorphy 
with flat face, short nose, small mouth and hypotelorism (Figs. 2c and 2d). At the sight of 
these clinical observations, we recommended a molecular diagnosis of HPE. Molecular 
testing of 18 HPE genes was performed on DNA of the daughter II1, revealing the presence of 
two compound heterozygous mutations in the minor HPE gene DISP1. Subsequently, to 
confirm the presence of HPE, MRI was performed and showed a mild form of lobar HPE with 
a very localized fusion of hemispheres in the forebrain (Fig. 2b).  
 
 
 
Whole Exome Sequencing  
WES was performed by the Genoscope on the DNA of the two parents II1 and II2 and one of 
the fetuses III2 in F1 family, using “SeqCap EZ Exome v3.0” capture (Roche) on 
HiSeqTM2000 platform (Illumina). Exomes were homogenously sequenced with a mean 
coverage of 93% of the targeted bases with read depth greater than 20X, and an overall mean 
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depth of coverage of 112X. Bioinformatic analyses were conducted with the Illumina pipeline 
analysis CASAVA 1.8. The sequenced reads were aligned on the reference human genome 19 
(hg19) with Eland v2.0 before variant calling (SNV and INDEL) with the CASAVA suite. 
Resulting variants were annotated using ANNOVAR v2.0 
(http://www.openbioinformatics.org/annovar/annovar_filter.html). Variants population 
frequencies were extracted from three different public databases (the Exome Sequencing 
Project (ESP6500), the 1000 Genomes Project (1000g, 2014) and the Exome Aggregation 
Consortium (ExAC02)). Several bioinformatics predictions tools were used to predict 
conservation (GERP++, PhyloP, SiPhy, and PhastCons Elements 46-way) (24-27) and 
deleterious effect of SNVs and INDELs (SIFT, PolyPhen-2 HDIV and HVAR, LRT, 
Mutation Taster, Mutation Assessor, FATHMM, Radial SVM, LR and CADD) (28-34). 
Visual inspection of candidate variants was performed with Integrative Genome Viewer 
(IGV, Broad Institute). 
 
Targeted high-throughput sequencing  
Targeted NGS was performed using Ion Torrent technology (Life Technologies) on DNA 
from the girl II1 in F2 family. Two pools of 711 primer pairs were designed (Ion Ampliseq 
technology, Life Technologies) to sequence all the exons of a panel of 18 genes involved in 
HPE or candidates (SHH, ZIC2, TGIF1, SIX3, DISP1, CDON, GAS1, SUFU, FGF8, FGFR1, 
NODAL, HHAT, SUFU, TDGF1, PTCH1, FOXH1, SOX2, DLL1) and 2 SHH expression 
regulatory regions, spanning 111kb. Libraries were sequenced with Ion PGMTM System (Life 
Technologies). A PGM-specific pipeline incorporated in the Ion Torrent server (Torrent Suite 
version 4.0.2; Life Technologies) was used to perform the following steps: reads alignment on 
hg19, targeted regions coverage analysis, filtering and removal of poor signal reads. Variant 
calling was performed with the Ion Torrent Variant Caller version 4.0. Mutations were 
annotated using ANNOVAR v2.0 as described for WES analysis and with Alamut software 
(Interactive Biosoftware). 
 
 
Sanger sequencing 
Sanger sequencing in F1 and F2 families assessed the intrafamilial segregation of the 
candidate mutations found by NGS. This was done using the BigDye terminator cycle 
sequencing kit (Applied Biosystems) on an ABI3130xl sequencer (Applied Biosystems) and 
analysed using SeqScape software v2.6 (Life Technologies).  
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Functional validation of the SHH p.Pro347Gln mutation 
The human SHH cDNA (RefSeq NM_000193) was cloned in a pMSCVneo (Clontech) vector. 
A mutated plasmid containing the SHH p.Pro347Gln mutation was obtained by site-directed 
mutagenesis using the QuikChange XL Site-directed Mutagenesis Kit (Stratagene, La Jolla, 
USA). Plasmids containing cDNA of SHH WT or SHH p.Pro347Gln were transfected in 
C3H10T1/2 cells using Transfast (Promega). Six days later, the alkaline phosphatase activity 
was measured as previously described (35), reliable to the differentiation of C3H10T1/2 into 
osteoblasts under SHH action.  
 
RESULTS 
 
F1 family 
In the F1 family, we showed by Sanger sequencing that a p.Pro347Gln mutation in SHH 
(c.1040C>A of RefSeq NM_000193) was present in fetuses III1, III2 and III3 inherited from 
the father II1 (Fig. 1a). It was inherited from the grandfather I1, and was also transmitted to 
the uncle II3, displaying microcephaly and hypotelorism. This uncle transmitted the SHH 
mutation to 3 children (III6, III7 and III9), also harbouring microcephaly and hypotelorism. 
WES analysis validated the known heterozygous SHH mutation in the father II1 presenting 
microcephaly and hypotelorism, and in the HPE fetus III2.  
 
The deleterious effect of the SHH p.Pro347Gln mutation was evaluated using an adaptation of 
a cell-based assay previously described (35). The efficiency of SHH signalisation in presence 
of the mutation was evaluated by quantifying the SHH-dependent differentiation of 
mesenchymal cells (C3H10T1/2) into osteoblasts. This was assessed by measuring the 
activity of the alkaline phosphatase (ALP) in C3H10T1/2 cells, 6 days after transfection with 
the pMSCVneo plasmids containing either cDNA of SHH WT or cDNA of SHH 
p.Pro347Gln. The ALP activity of the cells expressing the mutated SHH was 0,04 µU by µg 
of protein extract, while it was 1.31 µU/µg in the protein extract from cells expressing SHH 
WT, meaning that C3H10T1/2 cells failed to undergo osteoblastic differentiation under action 
of mutated SHH. This strongly reflects the deleteriousness of the p.Pro347Gln mutation (Fig. 
1b). 
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Based on the assumption that HPE observed in the fetus III2 resulted from the association of 
the SHH mutation with another mutation, variants were filtered according to this inheritance 
pattern. Only mutations inherited from the mother II2 were selected in the child III2. Intronic 
variants were filtered out, as well as synonymous variants and those that had a population 
allele frequency over 1% in any of the three public databases 1000g, ESP6500, and ExAC02. 
Thirty-four variants were selected, and a prioritization was performed using the cumulative 
predictions of ten bioinformatics tools. The 10 first-ranked candidate mutations are presented 
in supplementary data (Fig. S1). Most of these genes were already associated with genetic 
syndromes without any obvious link with forebrain development. We thus focused on a 
mutation in DISP1, known to be involved in HPE. This mutation is a substitution of a thymine 
in cytosine at location c.3287 of DISP1 (NM_032890), leading to the change of a methionine 
in threonine at location p.1096. This mutation was listed as rs144673025 in dbSNP database, 
and has a minor allele frequency of 0,55% in ESP6500, 0,1398% in 1000g, and 0,6189% in 
ExAC02. Three bioinformatics prediction tools classified this mutation as deleterious (LRT, 
Mutation Taster, and FATHMM) while other tools predicted it as tolerated (PolyPhen-2, 
SIFT, radial SVM, LR, and Mutation Assessor) (Table 4).  
 
We used Sanger sequencing to search for the DISP1 c.3287T>C mutation in individuals III3, 
III4 and III5 (Fig. 1). DNA was no longer available to look for this DISP1 mutation in fetus 
III1. A perfect co-segregation of the two mutations, SHH p.Pro347Gln and DISP1 
p.Met1096Thr was observed in HPE fetuses III2 and III3. Among the two healthy sisters, III4 
has no mutation whereas III5 carries the DISP1 mutation only. 
 
F2 family 
The F2 family was screened for 18 HPE candidate genes using targeted NGS for molecular 
diagnosis on the DNA of the daughter II1. Two heterozygous mutations were identified in the 
exon 10 of DISP1: the c.1087A>G transition leading to a missense mutation p.Asn363Asp 
and the c.1657G>A transition leading to a missense mutation p.Glu553Lys. Sanger 
sequencing on DNA of the parents showed that the p.Asn363Asp mutation was inherited from 
the father I1, and the p.Glu553Lys mutation was inherited from the mother I2 (Fig. 2a).  
The DISP1 p.Asn363Asp mutation was absent from public databases, and was predicted 
deleterious by 7 out of 10 of the prediction tools employed. The second mutation, 
p.Glu553Lys, was also predicted deleterious by the majority of the prediction tools, and was 
also absent from public sequencing databases (Table 4). According to the Alamut software 
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and the other conservation scores used, these two mutations were in highly conserved regions 
at both the nucleotide and the amino acid level. 
 
DISCUSSION 
 
The genetic heterogeneity of HPE is supported by reduced penetrance and the absence of 
obvious genotype-phenotype correlation. This is especially true for patients carrying 
heterozygous SHH mutations, as 45% harbor microforms, 45% present severe HPE and 10% 
are apparently asymptomatic (18).  Using WES, we report here the first co-segregation of 
mutations in SHH and DISP1 with severe HPE. Our results suggest that these mutations are 
combining to give a severe phenotype and provide strong evidence that digenic inheritance is 
a significant genetic model for HPE. 
 
Relationships between SHH and DISP1 in HPE 
In this study, we have investigated one family carrying a deleterious mutation in SHH and 
displaying variable expressivity of the disease. This mutation causes the change of proline in 
glutamine, which results in a severe reduction of SHH activity. Although microcephaly is not 
a typical sign of HPE, we can consider that the SHH mutation is responsible for this mild 
form of HPE in the present family (2). SHH mutation shows full penetrance with 
microcephaly whereas a second mutation in DISP1 seems to be necessary to obtain a more 
severe HPE in 3 fetuses. This is also supported by the finding that the mother and a clinically 
normal sister carried only the mutation in DISP1.  
 
In this study we also describe the first HPE case with compound heterozygous mutations in 
DISP1. Altogether, we find 3 different mutations (Fig. 3) in conserved regions of DISP1, 
including one in the Sterol Sensing Domain (SSD). The exact role of the SSD remains 
unclear, although most SSD containing proteins have been implicated in intracellular 
trafficking (36, 37). These 3 missense mutations in DISP1 provide new arguments for the 
implication of this gene in HPE. Few other mutations in DISP1 have been previously 
described in patient only harbouring microforms of HPE (38, 39). Noteworthy, all these 
DISP1 mutations were inherited from clinically unaffected parents. This gives evidence that 
additional factors are necessary to potentiate these mutations of DISP1 and to lead to HPE. As 
DISP1 mediates the secretion of SHH from producing cells, and allows consequent paracrine 
signalling (40), we hypothesized that these mutations have an impact on SHH signalling. 
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Mice data also strongly reveal the implication of Disp1 in HPE (40-42). Heterozygous 
knockout for Disp1 are undistinguishable from the wildtype whereas Disp1-/- embryos do not 
survive beyond E9.5 because of heart development defects. They also display cyclopia 
reminiscent to severe HPE (43). Further analysis of these mutants permitted to show that Shh 
signalling was disrupted in Disp1-/- embryos, indicating that Disp1 is essential for proper Shh 
signalling. Thus, Disp1 is most probably critical for ventral forebrain induction through its 
interaction with Shh pathway. Consequently, the co-segregation of a mutation in SHH and a 
mutation in DISP1 with severe HPE strongly suggests that cumulative effects lead to severe 
impairment of forebrain development. 
 
Inheritance in HPE 
Some authors have proposed autosomal recessive inheritance in HPE (3, 44). However, 
despite systematic sequencing, homozygous mutations in the major HPE genes SHH, ZIC2 
and SIX3, were never described in HPE cohorts (2, 5, 45). Nonetheless some autosomal 
recessive cases implicating minor HPE genes (Table 1) have been reported.  In 2007, a first 
case of recessive inheritance of TGIF1 mutations was described, with the finding of two 
compound heterozygous mutations (46). A loss of function homozygous mutation in FGF8 
has also been identified in one consanguineous HPE family (47). More recently, hypomorphic 
alleles of STIL were implicated in two cases of autosomal recessive inheritance in HPE 
patients (8, 9). It was proposed that STIL had a function during early brain development 
linked to SHH signalling (9, 48). Here, we describe a first HPE patient displaying two 
mutated DISP1 alleles whereas the two clinically normal parents carry only one mutated 
allele. This strongly supports that the presence of two mutations in a minor HPE gene 
exacerbates the risk of developing a HPE phenotype. Furthermore, the mild phenotype of the 
HPE patient described in this manuscript suggests that DISP1 activity is decreased such that it 
leads to a significant impairing of SHH pathway responsible for mild HPE, but above the 
threshold that would result in severe HPE and early lethality, as indicated by the mice model 
(43). 
 
Currently, single heterozygous mutations are mainly reported in HPE cases (Table 1) and 
believed to account for the HPE phenotype (5). But still, it cannot be excluded that a mutation 
in another gene may underlie the observed forebrain defects.  However, double heterozygous 
mutations for two HPE genes were rarely reported (Table 2). This is not really surprising 
because HPE genes are key developmental genes, and strong deleterious mutations in two of 
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these genes are probably not viable (44, 49). Thus, it is important to design the pipeline of 
WES analysis in order to avoid discarding mutations predicted to have a mildly deleterious 
effect in development genes. This strategy has enabled us to identify a new DISP1 mutation in 
a family presenting two fetuses with alobar and semi-lobar HPE associated to a deleterious 
mutation in SHH. The identification of these two altered genes that have functional 
relationships in multiple affected individuals in one family strongly supports a digenic 
inheritance (19). 
 
Polygenic inheritance has now been established for more and more other complex inheritance 
diseases among which digenic inheritance is the simplest form (19, 20). This mode of 
inheritance was reported in Kallmann syndrome (KS) (50), characterized by a defective 
hormonal reproductive axis and sense of smell. This developmental pathology was firstly 
described as autosomal dominant or X chromosome-linked. Further studies permitted to refine 
the genetics of KS syndrome by describing several patients harbouring two mutations in 
different genes (51, 52), combining major and minor KS genes, and giving evidence of a 
digenic inheritance of KS syndrome. This was also reported in patients with Alport syndrome, 
presenting mutations in two different collagen IV genes (COL4A3 and COL4A4) (53). In 
some nephropathies, mutations in two genes encoding glomerular proteins nephrin and 
podocin (NPHS1 and NPHS2) were identified in several patients (54). Such a multigenic 
inheritance is also well described in ciliopathies like Bardet-Biedl syndrome (BBS) with 
many patients harbouring mutations in two or more BBS genes (55). These cases illustrate 
how, in complex syndromes with variable severity, polygenic inheritance plays a role in the 
clinical expression of the disease. This is particularly relevant when there is functional 
relationships between mutated genes, as this is the case for HPE genes (44). A first online 
database dedicated to digenic diseases (DIDA, http://dida.ibsquare.be/) is now available (20). 
The cases described in our manuscript fully meet the required criteria to be included in DIDA 
database (20). 
 
By describing new HPE families with no classical autosomal dominant inheritance, our work 
refines the genetic bases of HPE. This discovery has significant implications for genetic 
counseling especially for risk assessment of patient relatives. Clinical geneticists have to be 
aware of such different patterns of heritability, and WES or at least sequencing of a large 
panel of HPE genes, should be performed to establish a molecular diagnosis.  
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Table 1. Characteristics of genes and mutations implicated in holoprosencephaly. 
The mutation frequencies are given in qualitative terms: “High” is for genes mutated in more 
than 10% of HPE cases, “Medium” for genes mutated between 10% and 1%, and “Low” for 
genes mutated in less than 1% of HPE cases. Mutation frequencies were calculated based on 
our local HPE cohort (>1000 cases). Mainly inherited: inherited mutations from a parent are 
predominant among the reported cases; inherited: All reported mutations are inherited from a 
parent; NA: inheritance information was not available. CNV or large indels encompassing 
whole genes are not included in this table. 
 
Table 2. Digenic inheritance in human HPE cases 
Mutations are given in proteic nomenclature, except the del18p11 which carries the TGIF1 
gene off. 
 
Tables 3. Phenotypic description of families F1 and F2 members. 
(a) Phenotypic description of family F1 members. The head circumferences of individuals 
harboring microcephaly are given in standard deviation (SD). Facial description of fetus III3 
was not available (NA). The dash means that the phenotype is normal. (b) Phenotypic 
description of family F2 members. M=Male, and F=Female. 
 
Table 4. Characteristics of DISP1 and SHH mutations found in F1 and F2 families 
Mutations reported in F1 family (DISP1 p.Met1096Thr; SHH p.Pro347Gln) and in F2 family 
(DISP1 p.Asn363Asp; DISP1 p.Glu553Lys) were annotated using ANNOVAR. Minor alleles 
frequencies were extracted from dbSNP build 138, in the Exome Sequencing Project 
containing sequencing data from 6500 exomes (ESP6500), in the 1000 Genome Project 
release of 2014 (1000G), and in the Exome Annotation Consortium (ExAC) containing 
sequencing data from 60700 exomes. Bioinformatic predictions were given by 10 predictions 
tools (SIFT, PolyPhen-2 HDIV and HVAR, LRT, Mutation Taster, Mutation Assessor, 
FATHMM, Radial SVM, LR and CADD). The cumulated predictions were given here, 
D=Deleterious, P=Possibly Deleterious, T=Tolerated.  
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TABLES 
 
Gene Chromosomal Locus 
Mutation frequency 
in nonsyndromic 
HPE 
Percentage of  
Inherited mutations 
from a parent 
Zygosity state References 
SHH 7q36 High (12%) 70% Heterozygous         (5, 23, 45, 56-58)  
ZIC2 13q32 Medium (9%) 30% Heterozygous         (5, 45, 59-62) 
SIX3 2p21 Medium (5%) 70% Heterozygous         (5, 45, 63-67) 
TGIF1 18p11.3 Medium (1,7%) Mainly inherited Heterozygous         (5, 68, 69) 
PTCH1 9q22.3 Low Mainly inherited Heterozygous         (4, 70, 71)  
TDGF1 3p23-p21 Low NA Heterozygous (10) 
GLI2 2q14 Low Mainly inherited Heterozygous (70, 72, 73)  
DISP1 1q42 Low Mainly inherited Heterozygous (38, 39) 
FGF8 10q24 Low Mainly  inherited Heterozygous         Homozygous (11, 47)  
FOXH1 8q24.3 Low NA Heterozygous (74) 
NODAL 10q22.1 Low NA Heterozygous (75) 
GAS1 9q21.33 Low Mainly inherited Heterozygous         (12) 
DLL1 6q27 Low Inherited Heterozygous (15) 
CDON 11q24.2 Low NA Heterozygous (13) 
STIL 1p33 Low Inherited Heterozygous Homozygous (8, 9, 76)  
 
Table 1. Characteristics of genes and mutations implicated in holoprosencephaly. 
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Gene Mutation References 
SHH p.Gly290Asp (23) 
ZIC2 p.Ala461_Ala470dup 
SHH p.Pro424Ala (23) 
TGIF1 del18p11 
SHH p.del378_380 (23) 
TGIF1 p.Thr151Ala 
GLI2 p.Arg151Gly (70) 
PTCH1 p.Thr328Ala 
SIX3 p.Ala93Asp (4) 
PTCH1 p.Ala393Thr 
SIX3 p.Ala284Pro (77) 
ZIC2 p.Trp304Arg 
SHH p.Leu218Pro 
(12) 
GAS1 p.Asp270Tyr 
SHH p.Cys363Tyr 
(12) 
GAS1 p.Asp288Gly 
SHH p.Pro347Gln In this report 
DISP1 p.Met1096Thr  
 
Table 2. Digenic inheritance in human HPE cases 
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(a) 
  Sex Age Brain MRI Face 
I1 M 81 Microcephaly (-5SD) - 
I2 F 79 - - 
II1 M 48 Microcephaly (-5SD) - 
II2 F 48 - - 
II3 M 46 Microcephaly (-4,5SD) Hypotelorism 
II5 M 42 - - 
II6 F 35 - - 
III1 M (fetus) - Semi-lobar HPE Proboscis                   Macroglossy 
III2 F (fetus) - Alobar HPE 
Flat face                    
hypotelorism              
Premaxillary agenesia         
Cleft lip/palate 
III3 F (fetus) - Severe HPE NA 
III4 F 12 - - 
III5 F 11 - - 
III6 M 12 Microcephaly (-4SD) Hypotelorism                Cleft lip/palate 
III7 M 11 Microcephaly (-3SD) - 
III8 F 9 - - 
III9 F 6 Microcephaly (-4SD) - 
 
(b)  
  Sex Age Brain MRI Face 
I1 M 34 - - 
I2 F 33 - - 
II1 F 9 Lobar HPE  Microcephaly (-2SD)            
Flat face                    
Short nose 
Hypotelorism                
Arched palate                
Cleft palate                  
Microstomia                 
Narrow palpebral fissures      
 
Tables 3. Phenotypic description of families F1 and F2 members. 
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Minor Allele Frequencies 
Gene 
Nucleic 
acid 
change 
Amino acid 
change dbSNP ESP6500 1000G ExAC 
Bioinformatic 
predictions 
DISP1 c.T3287C p.Met1096Thr rs144673025 0,005 0,001 0,006 D:3 P:1 T:6 
SHH c.C1040A p.Pro347Gln - 0 0 0 D:9 P:1 T:0 
DISP1 c.A1087G p.Asn363Asp - 0 0 0 D:7 P:2 T:1 
DISP1 c.G1657A p.Glu553Lys - 0 0 0 D:5 P:1 T:4 
 
Table 4. Characteristics of DISP1 and SHH mutations found in F1 and F2 families 
 
 
 
 
 
 
 
